These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 4120196)
41. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen. Cohen AM; Ketcham AS; Morton DL J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520 [No Abstract] [Full Text] [Related]
42. [Current problems in immunology]. Ambrosius H Z Gesamte Inn Med; 1974 Apr; 29(8):309-15. PubMed ID: 4137395 [No Abstract] [Full Text] [Related]
43. Production of antisera with specificity for malignant melanoma and human fetal skin. Fritze D; Kern DH; Drogemuller CR; Pilch YH Cancer Res; 1976 Feb; 36(2 Pt 1):458-66. PubMed ID: 56991 [TBL] [Abstract][Full Text] [Related]
46. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes. Huber SA; Lucas ZJ J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781 [No Abstract] [Full Text] [Related]
48. Stimulation of tumor cell growth in vitro: a critical evaluation of immunologic specificity. Lamon EW J Natl Cancer Inst; 1977 Sep; 59(3):769-74. PubMed ID: 70536 [No Abstract] [Full Text] [Related]
49. Report of a workshop on the immune response to solid tumours in man. Stevenson GT; Laurence DJ Int J Cancer; 1975 Dec; 16(6):887-96. PubMed ID: 53208 [No Abstract] [Full Text] [Related]
50. Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current status. Mavligit G; Gutterman JU; McBride C; Hersh EM Prog Exp Tumor Res; 1974; 19():222-52. PubMed ID: 4612607 [No Abstract] [Full Text] [Related]
54. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus. Jones JM; Jensen F; Veit B; Feldman JD J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500 [No Abstract] [Full Text] [Related]
55. Immune response to a transplantable malignant melanoma in mice. Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798 [No Abstract] [Full Text] [Related]
57. In vitro cytotoxicity of human lymphocytes: reduction of the lymphocyte cytotoxicity induced by antibodies or phytohemagglutinin by removing immune-complex-binding cells. Hallberg T Scand J Immunol; 1974; 3(5):645-54. PubMed ID: 4138557 [No Abstract] [Full Text] [Related]
58. Mechanisms of immunity in cancer. Baldwin RW Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216 [No Abstract] [Full Text] [Related]
59. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma. Perlmann P; O'Toole C; Unsgaard B Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587 [No Abstract] [Full Text] [Related]
60. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells. Bucana C; Hanna MG J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]